Consumer DNA testing company 23andMe is circling the drain. The company's CEO, Anne Wojcicki, plans to take the company ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

The company 23andMe is based out of San Francisco and is now left with a single board member, Wojcicki who controls 49.75 per ...

Once the domain of science fiction, neurotechnology is a reality with enormous implications for medicine and the digital ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

The company’s valuation had dropped from $6 billion in 2021, to under $150 million after going public and when CEO Anne Wojcicki pushed for a plan to buy it and take it private, the board rejected her ...

Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...

In 2009, Anne Wojcicki took a decisive step in her role as the leader of 23andMe, the genetic testing company she co-founded ...

A huge data breach followed by a plummeting valuation has stoked fears of a sale of 23andMe along with all of its customers' genetic data.